GlycoEra AG

Swiss Biotech Association

Member

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.

https://glycoera.com/
+41 44 733 85 75
veronica.gambillara@glycoera.com
Veronica Gambillara Fonck

Location

Grabenstrasse 3, 8952 Schlieren, Zürich, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2020
Number of employees in Switzerland

10-19

Key business

Core competencies

You may also be interested in

LATAM Pharma Innovative Ventures AG

LATAM Pharma offers made-to-measure solutions of immunization to public and private markets in Latin American and Caribbean countries.
6300 Zug

Member

ten23 health AG

ten23 health, headquartered in Basel, Switzerland, was founded in 2021. We are the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups: we develop, manufacture, and test tomorrow’s medicines.
4058 Basel

Member

Onward Therapeutics SA

We are a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.
1066 Épalinges

Member